Cancer burden and trends in the Asian Pacific Rim region

Asian Pacific Journal of Cancer Prevention

Volumn 5, Issue 2, 2004, Pages 96-117

  Yang, Binh H ^a   Parkin, D Maxwell ^b   Cai, Lin ^c   Zhang, Zuo Feng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Asian Pacific Rim; Cancer burden; Cancer projections; Prevention; risk factors; Time trends

Indexed keywords

CAUSE OF DEATH; FAR EAST; FEMALE; HEALTH EDUCATION; HUMAN; MALE; METHODOLOGY; NEOPLASM; PACIFIC ISLANDS; PATHOLOGY; PRIMARY PREVENTION; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SEX RATIO; SOCIOECONOMICS; SURVIVAL;

CAUSE OF DEATH; FAR EAST; FEMALE; HEALTH EDUCATION; HUMANS; MALE; NEOPLASMS; PACIFIC ISLANDS; PRIMARY PREVENTION; QUALITY OF LIFE; RISK ASSESSMENT; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS;

EID: 4344632581     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. Aguilar F, Hussain SP, Cerutti P (1993). Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci U S A, 90, 8586-90.
2. Alberts DS, Martinez ME, Roe DJ, et al (2000). Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med, 342, 1156-62.
3. American Cancer Society (2002). Cancer Facts & Figures 2002. American Cancer Society, Inc., Atlanta, GA.
4. Armitage P, Doll R (1954). The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer, 8, 1-12.
5. Beasley RP, Hwang LY, Lee GC, et al (1983). Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet, 2, 1099-102.
6. Bittencourt AL (1998). Vertical transmission of HTLV-I/II: a review. Rev Inst Med Trop Sao Paulo, 40, 245-51.
7. Blot WJ, Devesa SS, Fraumeni JF Jr (1993a). Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA, 270, 1320.
8. Blot WJ, Li JY, Taylor PR, et al (1993b). Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/ mineral combinations, cancer incidence, and disease- specific mortality in the general population. J Natl Cancer Inst, 85, 1483-92.
9. Boice JD Jr, Blettner M, Kleinerman RA, et al (1987). Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst, 79, 1295-311.
10. Brechot C (1998). Molecular mechanisms of hepatitis B and C viruses related to liver carcinogenesis. Hepatogastroenterology, 45 Suppl 3, 1189-96.
11. Butel JS, Lee TH, Slagle BL (1995). Viral co-factors in liver cancer: lessons from hepatitis B virus. Princess Takamatsu Symp, 25, 185-98.
12. Cai L, Yu SZ, Zhan ZF (2001). Cytochrome P450 2E1 genetic polymorphism and gastric cancer in Changle, Fujian Province. World J Gastroenterol, 7, 792-5.
13. Castellsague X, Munoz N (2003). Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr, 31, 20-8.
14. Chang MH, Chen CJ, Lai MS, et al (1997). Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med, 336, 1855-9.
15. Chang SS, Lu CL, Chao JY, et al (2002). Unchanging trend of adenocarcinoma of the esophagus and gastric cardia in Taiwan a 15-year experience in a single center. Dig Dis Sci, 47, 735-40.
16. Chen CJ, Liang KY, Chang AS, et al (1991). Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology, 13, 398-406.
17. Chen TT, Winder AE (1990). The opium wars revisited as US forces tobacco exports in Asia. Am J Public Health, 80, 659-62.
18. Connolly GN (1992). Worldwide expansion of transnational tobacco industry. J Natl Cancer Inst Monogr, 12, 29-35.
19. Cullins VE, Wright TC, Beattie DJ, Pollack AE (1999). Cervical cancer prevention using visual screening methods. Reproductive Health Matters, 7, 134-43.
20. Curtis RE, Boice JD Jr, Stovall M, et al (1992). Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med, 326, 1745-51.
21. de Koning HJ (2003). Mammographic screening: evidence from randomised controlled trials. Ann Oncol, 14, 1185-9.
22. Department of Cancer Control and Statistics OMCfCaCD (2003). Osaka Cancer Registry. http://www mc pref osaka jp/ocr_e/ ocr/#survival
23. Doll R (1996). Cancers weakly related to smoking. Br Med Bull, 52, 35-49.
24. Doll R, Cook P (1967). Summarizing indices for comparison of cancer incidence data. Int J Cancer, 2, 269-79.
25. Doll R, Peto R (1976). Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J, 2, 1525-36.
26. Ferlay J, Bray F, Pisani P, Parkin DM (2001). GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC CancerBase No. 5. IARC Press, Lyon, France
27. Fishman JA, Allison H, Knowles SB, et al (1999). State laws on tobacco control--United States, 1998. MMWR CDC Surveill Summ, 48, 21-40.
28. Friedman GD (1993). Cigarette smoking, leukemia, and multiple myeloma. Ann Epidemiol, 3, 425-8.
29. Gail MH, You WC, Chang YS, et al (1998). Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data. Control Clin Trials, 19, 352-69.
30. Gao YT, McLaughlin JK, Blot WJ, et al (1994). Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst, 86, 855-8.
31. Ghebranious N, Sell S (1998). Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice. Hepatology, 27, 383-91.
32. Giacosa A, Franceschi S, La Vecchia C, et al (1999). Energy intake, overweight, physical exercise and colorectal cancer risk. Eur J Cancer Prev, 8 Suppl 1, S53-S60.
33. Goodman MT, Moriwaki H, Vaeth M, et al (1995). Prospective cohort study of risk factors for primary liver cancer in Hiroshima and Nagasaki, Japan. Epidemiology, 6, 36-41.
34. Heck KE, Pamuk ER (1997). Explaining the relation between education and postmenopausal breast cancer. Am J Epidemiol, 145, 366-72.
35. Henschke CI, McCauley DI, Yankelevitz DF, et al (1999). Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet, 354, 99-105.
36. Herdman C, Sherris J (2000). Planning appropriate cervical prevention programs. Program for Appropriate Technology in Health, Seattle, WA.
37. Hino S, Katamine S, Miyata H, et al (1996). Primary prevention of HTLV-I in Japan. J Acquir Immune Defic Syndr Hum Retrovirol, 13 Suppl 1, S199-S203.
38. Hino S, Katamine S, Miyata H, et al (1997). Primary prevention of HTLV-1 in Japan. Leukemia, 11 Suppl 3, 57-9.
39. Hirata M, Hayashi J, Noguchi A, et al (1992). The effects of breastfeeding and presence of antibody to p40tax protein of human T cell lymphotropic virus type-I on mother to child transmission. Int J Epidemiol, 21, 989-94.
40. Ho GH, Phang BH, Ng IS, et al (2000). Novel germline BRCA1 mutations detected in women in singapore who developed breast carcinoma before the age of 36 years. Cancer, 89, 811-6.
41. Honjo K, Kawachi I (2000). Effects of market liberalisation on smoking in Japan. Tob Control, 9, 193-200.
42. Hu J, Nyren O, Wolk A, et al (1994). Risk factors for oesophageal cancer in northeast China. Int J Cancer, 57, 38-46.
43. International Agency for Research on Cancer (1994a). Hepatitis Viruses. Evaluation of Carcinogenic Risks to Humans, vol. 59. IARC, Lyon, France.
44. International Agency for Research on Cancer (1994b). Schistosomes, liver flukes and helicobacter pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 61. IARC, Lyon, France.
45. International Agency for Research on Cancer (1998). Carotenoids. IARC Handbooks of Cancer Prevention, vol. 2. IARC, Lyon, France.
46. International Agency for Research on Cancer (2003). Fruit and Vegetables. IARC Handbooks of Cancer Prevention, vol. 8. IARC, Lyon, France.
47. Kaldor JM, Day NE, Clarke EA, et al (1990). Leukemia following Hodgkin's disease. N Engl J Med, 322, 7-13.
48. Kanemura S, Tsuji I, Ohuchi N, et al (1999). A case control study on the effectiveness of breast cancer screening by clinical breast examination in Japan. Jpn J Cancer Res, 90, 607-13.
49. Ko YC, Cheng LS, Lee CH, et al (2000). Chinese food cooking and lung cancer in women nonsmokers. Am J Epidemiol, 151, 140-7.
50. Kolonel LN, Nomura AM, Hirohata T, et al (1981). Association of diet and place of birth with stomach cancer incidence in Hawaii Japanese and Caucasians. Am J Clin Nutr, 34, 2478-85.
51. Kondo T, Kono H, Miyamoto N, et al (1989). Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int J Cancer, 43, 1061-4.
52. Kuroishi T, Hirose K, Suzuki T, Tominaga S (2000). Effectiveness of mass screening for breast cancer in Japan. Breast Cancer, 7, 1-8.
53. Kusuhara K, Sonoda S, Takahashi K, et al (1987). Mother-to-child transmission of human T-cell leukemia virus type I (HTLV-I): a fifteen-year follow-up study in Okinawa, Japan. Int J Cancer, 40, 755-7.
54. Le Marchand L, Wilkens LR, Kolonel LN, et al (1997). Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res, 57, 4787-94.
55. Lee HP, Chia KS, Shanmugaratnam K (1992). Cancer Incidence in Singapore 1983-87. Singapore Cancer Registry, Singapore.
56. Li B, Taylor PR, Li JY, et al (1993). Linxian nutrition intervention trials. Design, methods, participant characteristics, and compliance. Ann Epidemiol, 3, 577-85.
57. Li H, Jin S, Xu H, Thomas DB (2000). The decline in the mortality rates of cervical cancer and a plausible explanation in Shandong, China. Int J Epidemiol, 29, 398-404.
58. Linet MS (1985). The Leukemias: Epidemiologic Aspects. Oxford University Press, New York.
59. Linet MS, Cartwright RA (1996). The Leukemias. In Cancer Epidemiology and Prevention. Schottenfeld D, Fraumeni JF, Jr. (Eds). Oxford University Press, New York pp 841-92.
60. Makimoto K, Higuchi S (1999). Alcohol consumption as a major risk factor for the rise in liver cancer mortality rates in Japanese men. Int J Epidemiol, 28, 30-4.
61. Morinaga K, Kishimoto T, Sakatani M, et al (2001). Asbestosrelated lung cancer and mesothelioma in Japan. Ind Health, 39, 65-74.
62. Muir C, Waterhouse J, Mack T, et al (1987). Cancer Incidence in Five Continents, vol. V. IARC Scientific Publications No. 88. IARC, Lyon, France.
63. Munoz N, Wahrendorf J, Bang LJ, et al (1985). No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus. Randomised double-blind intervention study in high-risk population of China. Lancet, 2, 111-4.
64. Oki T, Yoshinaga M, Otsuka H, et al (1992). A sero-epidemiological study on mother-to-child transmission of HTLV-I in southern Kyushu, Japan. Asia Oceania J Obstet Gynaecol, 18, 371-7.
65. Parkin DM, Bray FI, Devesa SS (2001). Cancer burden in the year 2000. The global picture. Eur J Cancer, 37 Suppl 8, S4-66.
66. Parkin DM, Muir CS, Whelan SL, et al (1992). Cancer Incidence in Five Continents, vol. VI. IARC Scientific Publications No. 120. IARC, Lyon, France.
67. Parkin DM, Pisani P (1999a). Gastric cancer. In Cancer Screening. Theory and Practice. Kramer BR, Gohagan JK, Prorok P (Eds). Dekker, New York pp 515-29.
68. Parkin DM, Pisani P, Lopez AD, Masuyer E (1994). At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer, 59, 494-504.
69. Parkin DM, Pisani P, Munoz N, Ferlay J (1999b). The global health burden of infection associated cancers. Cancer Surv, 33, 5-33.
70. Parkin DM, Whelan SL, Ferlay J, et al (1997). Cancer Incidence in Five Continents, vol. VII. IARC Scientific Publications No. 143. IARC, Lyon, France.
71. Parkin DM, Whelan SL, Ferlay J, et al (2002). Cancer Incidence in Five Continents, vol. VIII. IARC Scientific Publications No. 155. IARC, Lyon, France.
72. Patmasiriwat P, Bhothisuwan K, Sinilnikova OM, et al (2002). Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer. Hum Mutat, 20, 230.
73. Pisani P, Parkin DM, Bray F, Ferlay J (1999). Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 83, 18-29.
74. Pottern LM, Linet M, Blair A, et al (1991). Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma. Leuk Res, 15, 305-14.
75. Powell J, McConkey CC, Gillison EW, Spychal RT (2002). Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer, 102, 422-7.
76. Preston DL, Kusumi S, Tomonaga M, et al (1994). Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res, 137, S68-S97.
77. Qian GS, Ross RK, Yu MC, et al (1994). A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev, 3, 3-10.
78. Robison LL (1992). Down syndrome and leukemia. Leukemia, 6 Suppl 1, 5-7.
79. Rocken C, Carl-McGrath S (2001). Pathology and pathogenesis of hepatocellular carcinoma. Dig Dis, 19, 269-78.
80. Samet JM (1995). Lung Cancer. In Cancer Prevention and Control. Greenwald P, Kramer BS, Weed DL (Eds). Marcel Dekker Inc., New York pp 561-84.
81. Sankaranarayanan R, Basu P, Wesley RS, et al (2003). Visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. IARC, Lyon, France (in press).
82. Sankaranarayanan R, Black RJ, Parkin DM, eds (1998). Cancer Survival in Developing Countries. IARC Scientific Publications No. 145. IARC, Lyon, France.
83. Schatzkin A, Lanza E, Corle D, et al (2000). Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med, 342, 1149-55.
84. Setiawan VW, Zhang ZF, Yu GP, et al (2001). Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer, 92, 600-4.
85. Shimizu H, Mack TM, Ross RK, Henderson BE (1987). Cancer of the gastrointestinal tract among Japanese and white immigrants in Los Angeles County. J Natl Cancer Inst, 78, 223-8.
86. Siegel M (1993). Smoking and leukemia: evaluation of a causal hypothesis. Am J Epidemiol, 138, 1-9.
87. Smith MT (1996). The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ Health Perspect, 104 Suppl 6, 1219-25.
88. Sugiyama H, Doi H, Yamaguchi K, et al (1986). Significance of postnatal mother-to-child transmission of human Tlymphotropic virus type-I on the development of adult T-cell leukemia/lymphoma. J Med Virol, 20, 253-60.
89. Sun Z, Zhu Y, Stjernsward J, et al (1991). Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study. Cancer Detect Prev, 15, 313-8.
90. Tanaka K, Hirohata T, Koga S, et al (1991). Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res, 51, 2842-7.
91. Thomas DB, Gao DL, Ray RM, et al (2002). Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst, 94, 1445-57.
92. Tsukuma H, Ajiki W, Oshima A (1999). Cancer incidence and survival in Osaka. In Cancer epidemiology and control in the Asia-Pacific region International Center for Medical Research, Kobe University School of Medicine, Japan.
93. Tucker MA, Coleman CN, Cox RS, et al (1988). Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med, 318, 76-81.
94. Tucker MA, Meadows AT, Boice JD, Jr., et al (1987). Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst, 78, 459-64.
95. Ueno Y, Nagata S, Tsutsumi T, et al (1996). Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis, 17, 1317-21.
96. United Nations (2001). World Population Prospects. The 2000 Revision. United Nations, New York, Ref Type: Data File
97. United Nations Population Division (2002). World Urbanization Prospects: The 2001 Revision. United Nations, New York.
98. Vizcaino AP, Moreno V, Lambert R, Parkin DM (2002). Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer, 99, 860-8.
99. Waterhouse J, Muir C, Shanmugaratnam K, Powell J (1982). Cancer Incidence in Five Continents, vol. IV. IARC Scientific Publications No. 42. IARC, Lyon, France.
100. Weir HK, Thun MJ, Hankey BF, et al (2003). Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst, 95, 1276-99.
101. Wong VC, Ip HM, Reesink HW, et al (1984). Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis- B vaccine and hepatitis-B immunoglobulin. Doubleblind randomised placebo-controlled study. Lancet, 1, 921-6.
102. World Bank (1993). World development report 1993. Investing in Health. Oxford University Press, New York.
103. World Cancer Research Fund (WCRF) Panel (1997). Diet, Nutrition, and the Prevention of Cancer: A Global Perspective. World Cancer Research Fund, Washington, USA.
104. World Health Organization (1992). International Classification on Diseases and Related Health Problems, 1989 Revision. WHO, Geneva.
105. Xu ZY, Blot WJ, Xiao HP, et al (1989). Smoking, air pollution, and the high rates of lung cancer in Shenyang, China. J Natl Cancer Inst, 81, 1800-6.
106. Yang CS, Wang ZY (1993). Tea and cancer. J Natl Cancer Inst, 85, 1038-49.
107. Yang L, Parkin DM, Li L, Chen Y (2003). Time trends in cancer mortality in China: 1987-1999. Int J Cancer, 106, 771-83.
108. Yeh FS, Yu MC, Mo CC, et al (1989). Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res, 49, 2506-9.
109. Yin SN, Hayes RB, Linet MS, et al (1996). An expanded cohort study of cancer among benzene-exposed workers in China. Benzene Study Group. Environ Health Perspect, 104 Suppl 6, 1339-41.
110. Yoo KY, Kang D, Park SK, et al (2002). Epidemiology of breast cancer in Korea: occurrence, high-risk groups, and prevention. J Korean Med Sci, 17, 1-6.
111. Zhang H, Cai B (2003). The impact of tobacco on lung health in China. Respirology, 8, 17-21.
112. Zhang ZF (2002). Lung Cancer. In Encyclopedia of Public Health. Breslow L (Ed). Macmillan Reference USA, New York pp 702-4.
113. Zhang ZF, Yu SZ, Li WX, Choi BC (1989). Smoking, occupational exposure to rubber, and lung cancer. Br J Ind Med, 46, 12-5.
114. Zhong L, Goldberg MS, Gao YT, Jin F (1999a). A case-control study of lung cancer and environmental tobacco smoke among nonsmoking women living in Shanghai, China. Cancer Causes Control, 10, 607-16.
115. Zhong L, Goldberg MS, Gao YT, Jin F (1999b). Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China. Epidemiology, 10, 488-94.
116. Zhong L, Goldberg MS, Parent ME, Hanley JA (2000). Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. Lung Cancer, 27, 3-18.
117. Ziegler RG, Hoover RN, Pike MC, et al (1993). Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst, 85, 1819-27